Fox Chase Cancer Center News

​PHILADELPHIA, PA (May 15, 2017) – Springside Chestnut Hill Academy has awarded Rosaleen B. Parsons, MD, its Distinguished Alumnae Award. Parsons is chair of the Department of Diagnostic Imaging at Fox Chase Cancer Center, where she has worked since 1999.

PHILADELPHIA (May 15, 2017) – Medical oncologists Lori Goldstein, MD, and Elias Obeid, MD, MPH, are opening a phase 2 immunotherapy clinical trial for newly diagnosed, locally recurrent, or metastatic HER2-overexpressing breast cancer.

PHILADELPHIA (May 8, 2017) — May is Skin Cancer Awareness Month. When outdoors this season, remember to protect your skin from the sun’s damaging rays. According to the American Cancer Society (ACS), skin cancer is by far the most common type of cancer in the U.S. Fox Chase Cancer Center seeks to educate individuals on the early signs of skin cancer and steps you can take to prevent the disease.

PHILADELPHIA, PA (April 27, 2017) – Pooja Ghatalia, MD, a fellow in the Department of Hematology/Oncology at Fox Chase Cancer Center, has been awarded the Kidney Cancer Association Young Investigator Award. 

PHILADELPHIA, PA (April 27, 2017) In addition to the best clinical care available, Fox Chase Cancer Center is home to a team of world-renowned cancer researchers who develop and test therapies not available anywhere else.

PHILADELPHIA (April 24, 2017) — On Mother’s Day, May 14th, many members of the Fox Chase Cancer Center community will come together to participate in Susan G. Komen Philadelphia’s 27th Annual Race for the Cure.

PHILADELPHIA (April 13, 2017) – Genetics experts from Fox Chase Cancer Center are calling for more caution around how doctors assess genetic testing information for patients’ genetic predisposition to breast cancer risk.

PHILADELPHIA (April 10, 2017) — A new clinical study is available for prostate cancer patients who are concerned about recurrence. The study is using a new imaging agent to reveal how tissue and organs are functioning. In the study, researchers are examining whether this more targeted imaging can lead to changed or better treatment plans for patients.